About Us

Management Team

Gilles Avenard, MD – CEO

gilles_avenard-carre_300px-180x180-1Board member or advisor for several biotech companies ; co-founder and COO of BioAlliance Pharma SA – ONXEO (NYSE EURONEXT) until 2010. Gilles Avenard was involved in the development of several innovative medicines until their registration in Europe and the USA. Before that, he was Projects Director for Hoechst Marion Roussel (Sanofi) and Medical Director of Bio-Transfusion (LFB).

Olivier Favre Bulle, PhD – COO

cb-7045net_cropped-180x180Founder of 3Biotech, specialized in Pharmaceutical Development of Large and Small molecules. Site manager and European Head of Drug Development for Covance, Olivier also was head of NNE Pharmaplan France, a subsidiary of Novo Nordisk. He started at Rhône-Poulenc as Project Manager in Biological Drugs development. Chemical Engineer by training with a Ph.D in Bioengineering.

Eric Cohen, MBA – Finance Advisor

ericCEO and Founder of Agile Capital Markets; Advisor of several biotech & medtech companies; Investor Relations for Cellnovo Group. Eric was CFO of Mauna Kea Technologies (Euronext®: MKEA), Hybrigenics (Euronext®: ALHYG) and Teva Pharmaceuticals France (NASDAQ®: TLV) . He lead 2 IPO on Euronext® and several private and public financing round. He was also Head of Hybrigenics Business Services and Head of Operations (R&D and Production) at Mauna Kea.